Claes Gustafsson, Ph.D.
Chief Commercial Officer, ATUM
As ATUM’s Co-Founder and CCO, Dr. Gustafsson oversees most of the company’s external communications. Prior to co-founding ATUM, Dr. Gustafsson led, managed and collaborated with key strategic teams at Maxygen Inc. Before Maxygen, Dr. Gustafsson worked as a scientist at Kosan Biosciences, a number of research, teaching, and post-doctoral positions at UCs Santa Cruz and San Francisco, and at University of Umeå. He received his Ph.D. in Molecular Biology/Biochemistry from the University of Umeå, Sweden.
Talk to Dr. Gustafsson about these topics and more:
- GPS Platform
- Protein Engineering
- AI Machine Learning
- Protein Analytics
Ready to Connect?
Would you like to invite a health science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic:
About ATUM
ATUM is a fully integrated California based CRDO (Contract Research & Development Organization) biotechnology industry leader. ATUM, over the last two decades, has served life science researchers by delivering the highest quality services including gene design and gene synthesis, protein engineering, protein production, Leap-In Transposase®, cell line development, and master cell banking (MCB). With a state-of-the-art machine learning platform, proprietary algorithms and our fully integrated Laboratory Information Management System (LIMS), ATUM takes you from virtual sequence to MCB with a click of a button. ATUM provides a continual commitment to innovation where services are built on bioengineered solutions to bring speed to market, supporting you from pre-clinical research through IND and beyond. For more information, visit atum.bio.
Save this page as a PDF
